Marloes Hagens - Concepedia

Author

Marloes Hagens

University College London ORCID

Also Known As

M.H.J. Hagens, Marloes H. J. Hagens, Marloes H.J. Hagens, Marloes HJ Hagens, Marloes Hagens

Publications

465

Citations

H-Index

Concepts

All Affiliations

University College London National Hospital for Neurology and Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam University Medical Centers Vrije Universiteit Amsterdam

About

Marloes Hagens is an author at University College London specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	143
2	Neurology	2	2	143
3	Public Health	1	1	125
4	Epidemiology	1	1	125
5	Immunology	1	1	18

Marloes Hagens

Publications

437

Citations

H-Index

Page 1

	Year	Citations
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study Massimo Filippi, Paolo Preziosa, Alessandro Meani, The Lancet Neurology Multiple Sclerosis DiagnosisRetrospective StudyMcdonald CriteriaNeurological DisorderMedicine	2017	125
In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET Marloes Hagens, Sandeep S.V. Golla, Martijn T. Wijburg, Journal of Neuroinflammation	2018	79
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study Marloes Hagens, Sandeep S.V. Golla, Bieneke Janssen, European Journal of Nuclear Medicine and Molecular Imaging	2019	70
Three-Tesla MRI does not improve the diagnosis of multiple sclerosis Marloes Hagens, Jessica Burggraaff, Iris D. Kilsdonk, Neurology	2018	38
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study Marloes Hagens, Jessica Burggraaff, Iris D. Kilsdonk, Multiple Sclerosis Journal	2018	29
Cerebral rituximab uptake in multiple sclerosis: A <sup>89</sup>Zr-immunoPET pilot study Marloes Hagens, Joep Killestein, Maqsood Yaqub, Multiple Sclerosis Journal	2017	21
Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab Iris Dekker, Cyra E Leurs, Marloes Hagens, Multiple Sclerosis and Related Disorders RheumatologyAutoimmune DiseaseDisease ProgressionNeurological DisorderLong-term Disease Activity	2019	18
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis Ruth Geraldes, Maciej Juryńczyk, Giordani dos Passos, Journal of Neurology Neurosurgery & Psychiatry	2020	18
Single-subject structural cortical networks in clinically isolated syndrome Sara Collorone, Ferrán Prados, Marloes Hagens, Multiple Sclerosis Journal	2019	17
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease Ruth Geraldes, Maciej Juryńczyk, Giordani Rodrigues dos Passos, Multiple Sclerosis Journal	2020	11

Page 1